The lantibiotic mersacidin is a strong inducer of the cell wall stress response of Staphylococcus aureus

BMC Microbiology

Volumn 8, Issue , 2008, Pages

  Sass, Peter ^a   Jansen, Andrea ^a   Szekat, Christiane ^a   Sass, Vera ^a   Sahl, Hans Georg ^a   Bierbaum, Gabriele ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; LIPID II; MERSACIDIN; PROTEIN VRASR; REGULATOR PROTEIN; UNCLASSIFIED DRUG; VANCOMYCIN; ABC TRANSPORTER; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BACTERIOCIN; PEPTIDE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; CELL STRESS; CONCENTRATION RESPONSE; CULTURE MEDIUM; DRUG EFFECT; GENE DELETION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; TRANSCRIPTION REGULATION; VANCOMYCIN INTERMEDIATELY RESISTANT STAPHYLOCOCCUS AUREUS; VRAE GENE; BIOSYNTHESIS; CELL WALL; GENE EXPRESSION PROFILING; GENETICS; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGICAL EXAMINATION;

BACILLUS SP.; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BACTERIAL PROTEINS; BACTERIOCINS; CELL WALL; GENE DELETION; GENE EXPRESSION PROFILING; MICROBIAL SENSITIVITY TESTS; PEPTIDES; STAPHYLOCOCCUS AUREUS;

EID: 57049121174     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-8-186     Document Type: Article

References (39)

1. Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5. G Bierbaum C Szekat M Josten C Heidrich C Kempter G Jung HG Sahl, Appl Environ Microbiol 1996 62 385 392 8593044
2. Biosynthesis and biological activities of lantibiotics with unique post-translational modifications. HG Sahl RW Jack G Bierbaum, Eur J Biochem 1995 230 827 853 10.1111/j.1432-1033.1995.tb20627.x 7601145
3. Mersacidin, a new antibiotic from Bacillus. Fermentation, isolation, purification and chemical characterization. S Chatterjee DK Chatterjee SJ Lad MS Phansalkar RH Rupp BN Ganguli HW Fehlhaber H Kogler, J Antibiot (Tokyo) 1992 45 832 838 1500347
4. Lantibiotics: peptides of diverse structure and function. JM Willey WA van der Donk, Annu Rev Microbiol 2007 61 477 501 10.1146/annurev.micro.61. 080706.093501 17506681
5. Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria. HG Sahl G Bierbaum, Annu Rev Microbiol 1998 52 41 79 10.1146/annurev.micro.52.1.41 9891793
6. Constitution and solution conformation of the antibiotic mersacidin determined by NMR and molecular dynamics. T Prasch T Naumann RL Markert M Sattler W Schubert S Schaal M Bauch H Kogler C Griesinger, Eur J Biochem 1997 244 501 512 10.1111/j.1432-1033.1997.00501.x 9119018
7. The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. H Brötz G Bierbaum K Leopold PE Reynolds HG Sahl, Antimicrob Agents Chemother 1998 42 154 160 9449277
8. Combination of antibiotic mechanisms in lantibiotics. A Hoffmann U Pag I Wiedemann HG Sahl, Farmaco 2002 57 685 691 10.1016/S0014-827X(02)01208-9 12361237
9. Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. D Kruszewska HG Sahl G Bierbaum U Pag SO Hynes A Ljungh, J Antimicrob Chemother 2004 54 648 653 10.1093/jac/dkh387 15282239
10. Mersacidin, a new antibiotic from Bacillus. In vitro and in vivo antibacterial activity. S Chatterjee DK Chatterjee RH Jani J Blumbach BN Ganguli N Klesel M Limbert G Seibert, J Antibiot (Tokyo) 1992 45 839 845 1500348
11. Epidemiology and clinical impact of glycopeptide resistance in Staphylococcus aureus. C Ruef, Infection 2004 32 315 327 10.1007/s15010-004- 4124-7 15597220
12. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. M Kuroda H Kuroda T Oshima F Takeuchi H Mori K Hiramatsu, Mol Microbiol 2003 49 807 821 10.1046/j.1365-2958.2003.03599.x 12864861
13. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. S Utaida PM Dunman D Macapagal E Murphy SJ Projan VK Singh RK Jayaswal BJ Wilkinson, Microbiology 2003 149 2719 2732 10.1099/mic.0.26426-0 14523105
14. Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate- S. aureus-type resistance to vancomycin. F McAleese SW Wu K Sieradzki P Dunman E Murphy S Projan A Tomasz, J Bacteriol 2006 188 1120 1133 16428416 10.1128/JB.188.3.1120- 1133.2006
15. Cell envelope stress response in Gram-positive bacteria. S Jordan MI Hutchings T Mascher, FEMS Microbiol Rev 2008 32 107 146 18173394
16. Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization. A Muthaiyan JA Silverman RK Jayaswal BJ Wilkinson, Antimicrob Agents Chemother 2008 52 980 990 18086846 10.1128/AAC.01121-07
17. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. I Wiedemann E Breukink C van Kraaij OP Kuipers G Bierbaum B de Kruijff HG Sahl, J Biol Chem 2001 276 1772 1779 11038353
18. Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin. A Reipert K Ehlert T Kast G Bierbaum, Antimicrob Agents Chemother 2003 47 568 576 12543661 10.1128/AAC.47.2.568-576.2003
19. tcaA inactivation increases glycopeptide resistance in Staphylococcus aureus. H Maki N McCallum M Bischoff A Wada B Berger-Bächi, Antimicrob Agents Chemother 2004 48 1953 1959 15155184 10.1128/AAC.48.6.1953-1959.2004
20. Mode of action of human beta-defensin 3 (hBD3) against Staphylococcus aureus and transcriptional analysis of responses to defensin challenge. V Sass U Pag A Tossi G Bierbaum HG Sahl, Int J Med Microbiol 2008 epub, doi:10.1016/j.ijmm.2008.01.011. 18455476
21. Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. L Cui H Murakami K Kuwahara-Arai H Hanaki K Hiramatsu, Antimicrob Agents Chemother 2000 44 2276 2285 10952568 10.1128/AAC.44.9.2276-2285.2000
22. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. L Cui X Ma K Sato K Okuma FC Tenover EM Mamizuka CG Gemmell MN Kim MC Ploy N El Solh, J Clin Microbiol 2003 41 5 14 12517819 10.1128/JCM.41.1.5-14.2003
23. Antibiotic resistance as a stress response: complete sequencing of a large number of chromosomal loci in Staphylococcus aureus strain COL that impact on the expression of resistance to methicillin. H de Lencastre SW Wu MG Pinho AM Ludovice S Filipe S Gardete R Sobral S Gill M Chung A Tomasz, Microb Drug Resist 1999 5 163 175 10566865
24. Identification and analysis of Staphylococcus aureus components expressed by a model system of growth in serum. MD Wiltshire SJ Foster, Infect Immun 2001 69 5198 5202 11447207 10.1128/IAI.69.8.5198-5202.2001
25. Expression of tcaA and mprF and glycopeptide resistance in clinical glycopeptide-intermediate Staphylococcus aureus (GISA) and heteroGISA strains. M Wootton AP Macgowan TR Walsh, Biochim Biophys Acta 2005 1726 326 327 16213099
26. Strain dependence of the cell wall-damage induced stimulon in Staphylococcus aureus. N McCallum G Spehar M Bischoff B Berger-Bächi, Biochim Biophys Acta 2006 1760 1475 1481 16891058
27. VraSR two-component regulatory system and its role in induction of pbp2 and vraSR expression by cell wall antimicrobials in Staphylococcus aureus. S Yin RS Daum S Boyle-Vavra, Antimicrob Agents Chemother 2006 50 336 343 16377706 10.1128/AAC.50.1.336-343.2006
28. Lipid II-mediated pore formation by the peptide antibiotic nisin: a black lipid membrane study. I Wiedemann R Benz HG Sahl, J Bacteriol 2004 186 3259 3261 15126490 10.1128/JB.186.10.3259-3261.2004
29. Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method. M Kuroda K Kuwahara-Arai K Hiramatsu, Biochem Biophys Res Commun 2000 269 485 490 10.1006/bbrc.2000.2277 10708580
30. Bacitracin sensing in Bacillus subtilis. E Rietkötter D Hoyer T Mascher, Mol Microbiol 2008 68 768 785 10.1111/j.1365-2958.2008.06194.x 18394148
31. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. M Li DJ Cha Y Lai AE Villaruz DE Sturdevant M Otto, Mol Microbiol 2007 66 1136 1147 10.1111/j.1365-2958.2007.05986.x 17961141
32. Role of the single regulator MrsR1 and the two-component system MrsR2/K2 in the regulation of mersacidin production and immunity. A Guder T Schmitter I Wiedemann HG Sahl G Bierbaum, Appl Environ Microbiol 2002 68 106 113 11772616 10.1128/AEM.68.1.106-113.2002
33. Nutritional requirements for bacterial cell wall synthesis. GD Shockman MJ Conover JJ Kolb LS Riley G Toennies, J Bacteriol 1961 81 44 50 16561884
34. The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. H Brötz G Bierbaum PE Reynolds HG Sahl, Eur J Biochem 1997 246 193 199 10.1111/j.1432-1033.1997.t01-1-00193.x 9210483
35. In vitro activity of mersacidin (M87-1551), an investigational peptide antibiotic tested against gram-positive bloodstream isolates. MS Barrett RP Wenzel RN Jones, Diagn Microbiol Infect Dis 1992 15 641 644 10.1016/0732- 8893(90)90043-U 1424522
36. Ab initio structure determination of the lantibiotic mersacidin. TR Schneider J Karcher E Pohl P Lubini GM Sheldrick, Acta Crystallogr D Biol Crystallogr 2000 56 705 713 10.1107/S0907444900003711 10818347
37. Significance analysis of microarrays applied to the ionizing radiation response. VG Tusher R Tibshirani G Chu, Proc Natl Acad Sci USA 2001 98 5116 5121 11309499 10.1073/pnas.091062498
38. Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus. A Jansen M Türck C Szekat M Nagel I Clever G Bierbaum, Int J Med Microbiol 2007 297 205 215 10.1016/j.ijmm.2007.02.002 17418637
39. Ciprofloxacin and trimethoprim cause phage induction and virulence modulation in Staphylococcus aureus. C Goerke J Koller C Wolz, Antimicrob Agents Chemother 2006 50 171 177 16377683 10.1128/AAC.50.1.171-177.2006